Non-invasive detection of genomic imbalances in Hodgkin/Reed-Sternberg cells in early and advanced stage Hodgkin's lymphoma by sequencing of circulating cell-free DNA: A technical proof-of-principle study

The Lancet Haematology

Volumn 2, Issue 2, 2015, Pages e55-e65

  Vandenberghe, Peter ^a   Wlodarska, Iwona ^a   Tousseyn, Thomas ^a   Dehaspe, Luc ^a   Dierickx, Daan ^a   Verheecke, Magali ^a   Uyttebroeck, Anne ^a   Bechter, Oliver ^a   Delforge, Michel ^a   Vandecaveye, Vincent ^a   Brison, Nathalie ^a   Verhoef, Gregor E G ^a   Legius, Eric ^a   Amant, Frederic ^a   Vermeesch, Joris R ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

BLEOMYCIN; CASPASE 3; DACARBAZINE; DNA; DOXORUBICIN; VINBLASTINE;

ADOLESCENT; ADULT; AGED; AMNIOCENTESIS; ARTICLE; CANCER REGRESSION; CHILD; CHROMOSOME ABERRATION; CIRCULATING TUMOR CELL; CLINICAL ARTICLE; CLINICAL TRIAL (TOPIC); COMPARATIVE GENOMIC HYBRIDIZATION; COMPUTER ASSISTED EMISSION TOMOGRAPHY; DNA EXTRACTION; FEMALE; FETUS ECHOGRAPHY; FLUORESCENCE IN SITU HYBRIDIZATION; GENE SEQUENCE; GENETIC PARAMETERS; GENOMIC IMBALANCE; HODGKIN DISEASE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LYMPHADENOPATHY; MALE; MEDIASTINUM MASS; MIDDLE AGED; PRIORITY JOURNAL; PROSPECTIVE STUDY; REED STERNBERG CELL; SCHOOL CHILD; SIGNAL TRANSDUCTION; SYSTEMATIC REVIEW; WHOLE BODY MRI; YOUNG ADULT; BLOOD; DNA SEQUENCE; GENETICS; GENOMICS; PATHOLOGY; PREGNANCY;

ADOLESCENT; ADULT; AGED; CHILD; CHROMOSOME ABERRATIONS; COMPARATIVE GENOMIC HYBRIDIZATION; DNA; FEMALE; GENOMICS; HODGKIN DISEASE; HUMANS; MALE; MIDDLE AGED; PREGNANCY; PROSPECTIVE STUDIES; REED-STERNBERG CELLS; SEQUENCE ANALYSIS, DNA; YOUNG ADULT;

EID: 84923781055     PISSN: None     EISSN: 23523026     Source Type: Journal    
DOI: 10.1016/S2352-3026(14)00039-8     Document Type: Article

References (31)

1. Stein H Hodgkin lymphoma. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues 2008, IARC, Lyon. S.H. Swerdlow, E. Campo, N.L. Harris (Eds.).
2. Steidl C, Connors JM, Gascoyne RD Molecular pathogenesis of Hodgkin's lymphoma: increasing evidence of the importance of the microenvironment. J Clin Oncol 2011, 29:1812-1826.
3. Kuppers R, Engert A, Hansmann ML Hodgkin lymphoma. J Clin Invest 2012, 122:3439-3447.
4. Chui DT, Hammond D, Baird M, Shield L, Jackson R, Jarrett RF Classical Hodgkin lymphoma is associated with frequent gains of 17q. Genes Chromosomes Cancer 2003, 38:126-136.
5. Hartmann S, Martin-Subero JI, Gesk S, et al. Detection of genomic imbalances in microdissected Hodgkin and Reed-Sternberg cells of classical Hodgkin's lymphoma by array-based comparative genomic hybridization. Haematologica 2008, 93:1318-1326.
6. Joos S, Menz CK, Wrobel G, et al. Classical Hodgkin lymphoma is characterized by recurrent copy number gains of the short arm of chromosome 2. Blood 2002, 99:1381-1387.
7. Slovak ML, Bedell V, Hsu YH, et al. Molecular karyotypes of Hodgkin and Reed-Sternberg cells at disease onset reveal distinct copy number alterations in chemosensitive versus refractory Hodgkin lymphoma. Clin Cancer Res 2011, 17:3443-3454.
8. Steidl C, Telenius A, Shah SP, et al. Genome-wide copy number analysis of Hodgkin Reed-Sternberg cells identifies recurrent imbalances with correlations to treatment outcome. Blood 2010, 116:418-427.
9. Diaz LA, Bardelli A Liquid biopsies: genotyping circulating tumor DNA. J Clin Oncol 2014, 32:579-586.
10. Bianchi DW, Wilkins-Haug L Integration of noninvasive DNA testing for aneuploidy into prenatal care: what has happened since the rubber met the road?. Clin Chem 2014, 60:78-87.
11. Chan KC, Jiang P, Zheng YW, et al. Cancer genome scanning in plasma: detection of tumor-associated copy number aberrations, single-nucleotide variants, and tumoral heterogeneity by massively parallel sequencing. Clin Chem 2013, 59:211-224.
12. Heitzer E, Ulz P, Belic J, et al. Tumor-associated copy number changes in the circulation of patients with prostate cancer identified through whole-genome sequencing. Genome Med 2013, 5:30.
13. Leary RJ, Sausen M, Kinde I, et al. Detection of chromosomal alterations in the circulation of cancer patients with whole-genome sequencing. Sci Transl Med 2012, 4:162ra54.
14. Thierry AR, Mouliere F, El Messaoudi S, et al. Clinical validation of the detection of KRAS and BRAF mutations from circulating tumor DNA. Nat Med 2014, 20:430-435.
15. Bayindir B, Dehaspe L, Brison N, et al. Non-invasive prenatal Testing (NIPT) using a novel analysis pipeline to screen for all autosomal fetal aneuploidies improves pregancy management. Eur J Hum Genet; published online Jan 14. DOI:10.1038/ejhg.2014.282.
16. Cheson BD, Fisher RI, Barrington SF, et al. Recommendations for initial evaluation, staging, and response assessment of Hodgkin and Non-Hodgkin lymphoma: the Lugano classification. J Clin Oncol 2014, 32:3059-3067.
17. Mayerhoefer ME, Karanikas G, Kletter K, et al. Evaluation of diffusion-weighted MRI for pretherapeutic assessment and staging of lymphoma: results of a prospective study in 140 patients. Clin Cancer Res 2014, 20:2984-2993.
18. Rengstl B, Newrzela S, Heinrich T, et al. Incomplete cytokinesis and re-fusion of small mononucleated Hodgkin cells lead to giant multinucleated Reed-Sternberg cells. Proc Natl Acad Sci USA 2013, 110:20729-20734.
19. Weber-Matthiesen K, Deerberg J, Poetsch M, Grote W, Schlegelberger B Numerical chromosome aberrations are present within the CD30+ Hodgkin and Reed-Sternberg cells in 100% of analyzed cases of Hodgkin's disease. Blood 1995, 86:1464-1468.
20. Hohaus S, Giachelia M, Massini G, et al. Cell-free circulating DNA in Hodgkin's and non-Hodgkin's lymphomas. Ann Oncol 2009, 20:1408-1413.
21. Mussolin L, Burnelli R, Pillon M, et al. Plasma cell-free DNA in paediatric lymphomas. J Cancer 2013, 4:323-329.
22. Bai M, Papoudou-Bai A, Horianopoulos N, Grepi C, Agnantis NJ, Kanavaros P Expression of bcl2 family proteins and active caspase 3 in classical Hodgkin's lymphomas. Hum Pathol 2007, 38:103-113.
23. Tiacci E, Doring C, Brune V, et al. Analyzing primary Hodgkin and Reed-Sternberg cells to capture the molecular and cellular pathogenesis of classical Hodgkin lymphoma. Blood 2012, 120:4609-4620.
24. Gallamini A, Barrington SF, Biggi A, et al. The predictive role of interim positron emission tomography for Hodgkin lymphoma treatment outcome is confirmed using the interpretation criteria of the Deauville five-point scale. Haematologica 2014, 99:1107-1113.
25. Martin-Subero JI, Gesk S, Harder L, et al. Recurrent involvement of the REL and BCL11A loci in classical Hodgkin lymphoma. Blood 2002, 99:1474-1477.
26. Kato M, Sanada M, Kato I, et al. Frequent inactivation of A20 in B-cell lymphomas. Nature 2009, 459:712-716.
27. Green MR, Monti S, Rodig SJ, et al. Integrative analysis reveals selective 9p24.1 amplification, increased PD-1 ligand expression, and further induction via JAK2 in nodular sclerosing Hodgkin lymphoma and primary mediastinal large B-cell lymphoma. Blood 2010, 116:3268-3277.
28. Van Roosbroeck K, Cox L, Tousseyn T, et al. JAK2 rearrangements, including the novel SEC31A-JAK2 fusion, are recurrent in classical Hodgkin lymphoma. Blood 2011, 117:4056-4064.
29. Hao Y, Chapuy B, Monti S, Sun HH, Rodig SJ, Shipp MA Selective JAK2 inhibition specifically decreases Hodgkin lymphoma and mediastinal large B-cell lymphoma growth in vitro and in vivo. Clin Cancer Res 2014, 20:2674-2683.
30. Osborne CM, Hardisty E, Devers P, et al. Discordant noninvasive prenatal testing results in a patient subsequently diagnosed with metastatic disease. Prenat Diagn 2013, 33:609-611.
31. Ferlay J, Soerjomataram I, Ervik M, et al. Globocan 2012. Estimated cancer incidence, mortality and prevalence wordwide in 2012 (accessed Sept 29, 2014). http://globocan.iarc.fr/Pages/age-specific_table_sel.aspx.